Roberto Padoan

19PUBLICATIONS
57CO-AUTHORS
Epidemiological modellingAutoimmunityGlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 21, 2026
Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.

|Apr 21, 2026
Monoclonal antibodies targeting IL-5/5R or IL-4/13 pathways in eosinophilic myocarditis: a single-centre experience and systematic literature review.

|Mar 23, 2026
Evolving Therapeutic Strategies in ANCA-Associated Vasculitis: Current Standards and Emerging Targets for GPA and MPA.

Roberto Dal Pozzolo, Luca Iorio, Federica Davanzo

|Jan 12, 2026
Outcomes of an Intravenous to Subcutaneous Infliximab (CT-P13) Strategy in Takayasu Arteritis: A Proof-of-Concept Prospective Study.

Luca Iorio, Federica Davanzo, Eleonora Fiorin

|Nov 03, 2025
Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience.

Federica Davanzo, Luca Iorio, Marta Codirenzi

|Mar 12, 2025
Advances in the treatment of polymyalgia rheumatica.

Luca Iorio, Milena Bond, Roberto Padoan

Pageof 4

Frequent Collaborators

8 joint publications

Andrea Doria

6 joint publications

Luca Iorio

3 joint publications

Federica Davanzo

2 joint publications

Diego Cazzador